brain tumor

Northwell experts update brain cancer biotechnology

By GREGORY ZELLER // A Northwell Health inner circle with deep biotechnology roots has issued a “comprehensive update” of breakthroughs in brain tumor research. The roadmap of next-generation advances in the difficult war against brain cancers comes from physicians at New York City’s Lenox Hill Hospital, by way of the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Feinstein Institutes for Medical Research, famed bioscience hub. The team on Thursday announced a…


Feinstein researchers eye brain-tumor breakthrough

A common medication used to treat parasitic infections could leapfrog to the top of medical science’s brain-cancer arsenal. Pure scientific research funded by federal grants has led to this potential oncological breakthrough by the Feinstein Institute for Medical Research, the research-and-development division of the Northwell Health system. Marc Symons, a professor in the Feinstein Institute’s Karches Center for Oncology Research, is exploring the use of mebendazole – a medication commonly used to treat pinworms –…